Association for Japan Health Food Certified
JHFC
← Back to Resources

Lactic Acid Bacteria / Probiotics: Ingredient Quantity Labeling Standards and Cross-Border Compliance Guide

---

Abstract

The global market circulation of lactic acid bacteria and probiotic health food products continues to expand, and the compliance challenges consumers face when making cross-border purchases are growing in tandem. This paper systematically reviews current rules across three dimensions: ingredient quantity labeling standards, Japan's domestic labeling regulatory framework, and cross-border purchase compliance considerations, with the aim of helping consumers and procurement parties establish verifiable standards for evaluating product information. The content of this paper is strictly limited to objective dimensions such as labeling, testing, raw material origin, and traceability, and does not involve any claims regarding medical efficacy.

---

I. Basic Definitions and Product Classification

Lactic Acid Bacteria (LAB) is a collective term for microorganisms capable of fermenting sugars to produce lactic acid, encompassing multiple genus-level classifications including *Lactobacillus*, *Bifidobacterium*, *Streptococcus*, and others. Probiotics is a functional concept jointly defined in 2001 by the Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO) as "live microorganisms which, when administered in adequate amounts, confer a health benefit on the host." This definition is itself a scientific classification statement, not a product efficacy claim.

In the market, lactic acid bacteria products are primarily divided into the following three regulatory tiers:

Identifying which regulatory category a product belongs to is the first step in interpreting its label information.

---

II. Ingredient Quantity Labeling Standards: Interpretation of Key Indicators

2.1 Strain-Level Identification

Internationally recognized best practices for probiotic labeling (with reference to FAO/WHO guidelines and ISAPP — the International Scientific Association for Probiotics and Prebiotics — position statements) require labeling to the precise strain level, not merely to the genus or species name. For example:

The importance of strain-level identification lies in the fact that biological characteristics differ significantly between strains. Consumers and researchers need strain information to consult the corresponding publicly available literature and safety data — this is a fundamental requirement of information transparency.

2.2 Colony Count (CFU) Labeling Methods

Viable cell counts are typically expressed in CFU (Colony Forming Units). Labels should be examined carefully for the following distinction between two different labeling time points:

Labeling MethodMeaningCompliance Considerations
*Seizōji kikinsū* (Colony count at time of manufacture)Viable cell count as of the manufacturing dateDoes not reflect actual viable cell count at end of shelf life
*Shōmi kigen-ji kikinsū* (Colony count at end of best-before date)Guaranteed viable cell count through the labeled best-before dateMore informative and useful for consumers

Japan's *Foods with Function Claims* notification rules, as well as the voluntary standards of industry organizations such as JHNFA (Japan Health and Nutrition Food Association), encourage businesses to label guaranteed viable cell counts at end of shelf life, to ensure that the information provided to consumers corresponds to the actual condition of the product at the time of consumption.

2.3 Viability Assurance Conditions

Viable cell counts are closely tied to storage conditions. Compliant labels should clearly state the storage temperature requirements corresponding to the guaranteed viable cell count (e.g., refrigeration required, stable at room temperature, protect from light, etc.) as well as the period of use after opening. If labels do not disclose this information, consumers have no way of determining whether the product they purchased maintained its labeled viable cell count under the prescribed conditions.

2.4 Quantity Labeling for Other Ingredients

In addition to colony counts, lactic acid bacteria products frequently contain auxiliary ingredients such as prebiotics (e.g., inulin, oligosaccharides), vitamins, and minerals. Under Japan's *Food Labeling Act* and *Nutrition Labeling Standards*, the nutrition facts panel must, in the prescribed format, declare mandatory items including energy, protein, fat, carbohydrates, and sodium. Other ingredients may be voluntarily declared according to product characteristics, but declared values must be supported by analytical evidence and may not be falsely stated.

---

III. Japan's Domestic Labeling Compliance Framework

3.1 Principal Regulatory System

Health food labeling in Japan is subject to the overlapping jurisdiction of multiple laws and regulations:

3.2 GMP Certification and Manufacturing Traceability

The manufacturing quality of a product forms the foundation of label credibility. At the industry level in Japan, JHNFA operates a GMP Conformity Certification program, under which factories applying for certification undergo third-party audits covering raw material management, manufacturing processes, quality inspection, and shipment management. Factories that pass certification are issued a certification number and are subject to periodic review audits and spot inspections.

Consumers may use the certified factory directory on the JHNFA official website to verify the certification status and validity period of the corresponding factory by entering the certification number displayed on the product packaging. This is a practicable, objective indicator for assessing the management standards of the manufacturer.

3.3 Mandatory Label Information Checklist

Under the current *Food Labeling Act*, labels on lactic acid bacteria health food products sold in Japan must include (non-exhaustively):

---

IV. Compliance Considerations for Cross-Border Purchases

4.1 Product Categories and Regulatory Correspondence in the Destination Country

Products lawfully marketed in Japan must comply with the regulatory requirements of the destination country upon entering other national markets. Taking mainland China as an example:

Standard General Trade Import (Direct Import): Lactic acid bacteria health foods, if sold in China under a health function claim, must be registered with (for first-time importers) or filed with the State Administration for Market Regulation (SAMR) in accordance with the *Measures for the Registration and Filing Administration of Health Foods*. Chinese-language labels are required, and label content must receive regulatory approval. Products that have not been registered or filed may not be sold domestically in China as health foods.

Cross-Border E-Commerce Channels: Under the *List of Cross-Border E-Commerce Retail Import Commodities* (the cross-border e-commerce positive list) and related regulations, personal-use products purchased through legitimate cross-border e-commerce platforms are subject to different regulatory rules than general trade. However, they remain subject to individual annual purchase limits (currently RMB 26,000) and per-transaction limits, and may not be resold. Purchasers bear compliance responsibility in their capacity as individual consumers.

United States Market: Lactic acid bacteria products are typically classified as Dietary Supplements, subject to the FDA's Dietary Supplement Health and Education Act (DSHEA, 1994). Labels must include a "Supplement Facts" panel and must carry the FDA standard disclaimer: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." Any structure/function claims must be substantiated and the FDA must be notified within 30 days of market entry.

European Union Market: Under the Food Supplements Directive (Directive 2002/46/EC) and the Health Claims Regulation (EC No 1924/2006), there are currently no EU-level approved general health claims for probiotics. Businesses may not attach functional claims to the word "probiotics" on product labels or in advertising; doing so constitutes a violation. Rules at the individual Member State level vary.

4.2 Label Language Compliance for Cross-Border Purchases

Most countries require foods sold domestically to be labeled in the country's official language. The lawful pathways for -labeled products to enter the Chinese market require:

Consumers who obtain products through overseas purchasing agents (*haitao daigou*) should note that purchasing agent activity that exceeds the scope of personal use constitutes a potential regulatory violation, and such products cannot benefit from the after-sales service and quality assurances of official distribution channels.

4.3 Key Customs Inspection Points

Customs authorities in various countries typically focus on the following when inspecting imported health foods:

Consumers are advised to confirm the admission status of the relevant probiotic strains in the destination country before making a purchase, as some countries impose explicit restrictions on strains at specific genus levels.

---

V. Actionable Steps for Consumers

The following are specific verification steps compiled from the compliance framework above. Consumers may work through this checklist prior to making a purchase:

---

Conclusion

Compliant labeling of lactic acid bacteria and probiotic products is, at its core, an expression of information transparency: accurate strain-level identification, a verifiable viable cell count guarantee, and labeling logic that corresponds to storage conditions together form the basis upon which consumers can make rational comparisons when making purchasing decisions. Cross-border purchases add further dimensions, including regulatory differences in the destination country, channel compliance, and label language requirements.

When evaluating products from diverse sources, the most effective safeguard available to consumers is to return to verifiable, objective information: certification numbers that can be looked up, filing records that can be searched, and batch reports that can be requested. For any product that cannot provide the above basic information, the reliability of its label claims should be treated with appropriate caution. The compliance framework described in this paper is based on currently effective regulations; should relevant provisions be updated, the most recent versions published by the competent authorities shall prevail.

---

*This paper is for informational purposes only and does not constitute legal advice. For specific compliance matters, please consult a qualified food regulatory professional or your local competent authority.*

This document concerns quality/transparency only and makes no claim of pharmaceutical efficacy or disease treatment/prevention.
← Back to Resources